H1 FY27 profit jumps 365%; IBC commissioning targeted for Q3 FY27

Management guided margin improvementInvestor Communications View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.5%Reaction day

₹207.00

prior close

₹190.05

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-9.0% vs market

Packaging peers, median of 63sector+0.0%-7.5% vs sector

On the reaction day the stock moved 9.0 pts less than Nifty Microcap 250 and 7.5 pts less than its Packaging peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.6

10m

+1.0

15m

+1.8

30m

+1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.5+1.4-9.0+0.0-7.5

Next day

-9.7+1.7-11.4+0.8-10.4

-8.2+3.9-12.1+2.7-10.9

-10.1+5.1-15.2+3.6-13.7

-11.1pendingpending+2.7-13.8

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Packaging peers, median of 63Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

H1 FY27 revenue rose 7% to Rs 19,095 lakh, EBITDA climbed 151% to Rs 2,738 lakh and margin expanded to 14% from 6%. Net profit rose 365% to Rs 1,484 lakh, while hospital furniture revenue grew 30% to Rs 2,985 lakh. The high-margin IBC unit at Khalapur is targeted to start in Q3 FY27.

Likely market impact

Strong profit and margin gains should support the stock. IBC commissioning may add growth, though the Rs 1,000 crore revenue target has no stated timeline.